https://currentscience.info/index.php/cs/issue/feedCurrent Science2026-09-14T15:54:14+00:00Olivier Raspé editor@currentscience.infoOpen Journal Systems<p>ISSN: 2795-8639</p> <p><strong>Current Science</strong> publishes original research, reviews and case studies on all areas of Science. The journal is intended as a medium for communication and discussion of important issues that concern science and scientific activities. Besides full length research articles and shorter research communications, the journal publishes review articles, scientific correspondence and commentaries, news and views, comments on recently published research papers, opinions on scientific activity, articles on universities, Indian laboratories and institutions, interviews with scientists, personal information, book reviews, etc. It is also a forum to discuss issues and problems faced by science and scientists and an effective medium of interaction among scientists in the country and abroad. </p> <p><strong>Peer-review.</strong> The journal uses double-blind peer review (neither the authors nor the reviewers know the identity of each other) to avoid bias. See more information <<a href="https://currentscience.info/index.php/cs/peerreview">Peer Review</a>>. Current Science complies with the Committee on Publication Ethics Guidelines for Peer Reviewers which provides a comprehensive guide to the ethics of peer review. See more information <<a href="https://currentscience.info/index.php/cs/guidelinesforreviewers">Guidelines for Reviewers</a>>. </p> <p><strong>Journal policies.</strong> The journal provides its’ policies, which include detailed information about submission, editorial and publishing processes and guidelines for authors and reviewers. All parties are being introduced with their rights and responsibilities to ensure smooth and ethical publishing process. See more information <<a href="https://currentscience.info/index.php/cs/journalpolicies">Journal Policies</a>></p> <p><strong>Fees and Charges.</strong> The journal operates as open access journal, the publishing process is covered by Article Publication Charges (APCs) See more information <<a href="https://currentscience.info/index.php/cs/feesandcharges%20">Fees and Charges</a>></p> <p data-start="116" data-end="279"><strong data-start="116" data-end="126">Article Withdrawal </strong></p> <p data-start="116" data-end="279"><strong data-start="116" data-end="126">Scope.</strong> This policy applies to submissions made to <em data-start="170" data-end="187">Current Science</em> at any time from initial submission through publication. It aligns with COPE best-practice.</p> <h2 data-start="281" data-end="313">1) When can authors withdraw?</h2> <ul data-start="314" data-end="643"> <li data-start="314" data-end="374"> <p data-start="316" data-end="374"><strong data-start="316" data-end="365">Before editor assignment / initial screening:</strong> Allowed.</p> </li> <li data-start="375" data-end="427"> <p data-start="377" data-end="427"><strong data-start="377" data-end="399">Under peer review:</strong> Allowed with justification.</p> </li> <li data-start="428" data-end="521"> <p data-start="430" data-end="521"><strong data-start="430" data-end="471">After acceptance (before production):</strong> Strongly discouraged; allowed with justification.</p> </li> <li data-start="522" data-end="643"> <p data-start="524" data-end="643"><strong data-start="524" data-end="569">In production / Online-first / Published:</strong> Treated as a <em data-start="583" data-end="595">retraction</em> or <em data-start="599" data-end="608">removal</em> and follows our Retraction Policy.</p> </li> </ul> <h2 data-start="645" data-end="686">2) Fee schedule (administrative costs)</h2> <div class="_tableContainer_1rjym_1"> <div class="group _tableWrapper_1rjym_13 flex w-fit flex-col-reverse" tabindex="-1"> <table class="w-fit min-w-(--thread-content-width)" data-start="687" data-end="1420"> <thead data-start="687" data-end="760"> <tr data-start="687" data-end="760"> <th data-start="687" data-end="713" data-col-size="md">Stage of the manuscript</th> <th data-start="713" data-end="739" data-col-size="md">What we’ve already done</th> <th data-start="739" data-end="760" data-col-size="md">Withdrawal charge</th> </tr> </thead> <tbody data-start="775" data-end="1420"> <tr data-start="775" data-end="851"> <td data-start="775" data-end="808" data-col-size="md"><strong data-start="777" data-end="807">Before editorial screening</strong></td> <td data-col-size="md" data-start="808" data-end="834">Submission receipt only</td> <td data-col-size="md" data-start="834" data-end="851"> US$0</td> </tr> <tr data-start="852" data-end="960"> <td data-start="852" data-end="900" data-col-size="md"><strong data-start="854" data-end="899">After screening / invited for peer review</strong></td> <td data-col-size="md" data-start="900" data-end="937">Editorial checks, reviewer invites</td> <td data-col-size="md" data-start="937" data-end="960">US$ 50</td> </tr> <tr data-start="961" data-end="1094"> <td data-start="961" data-end="1022" data-col-size="md"><strong data-start="963" data-end="1021">Under review (reviews received / revision in progress)</strong></td> <td data-col-size="md" data-start="1022" data-end="1070">Review management, reviewer honoraria, checks</td> <td data-col-size="md" data-start="1070" data-end="1094">US$ 100</td> </tr> <tr data-start="1095" data-end="1186"> <td data-start="1095" data-end="1129" data-col-size="md"><strong data-start="1097" data-end="1128">Accepted, before production</strong></td> <td data-col-size="md" data-start="1129" data-end="1161">Final checks, acceptance docs</td> <td data-col-size="md" data-start="1161" data-end="1186">US$150</td> </tr> <tr data-start="1187" data-end="1285"> <td data-start="1187" data-end="1236" data-col-size="md"><strong data-start="1189" data-end="1235">In production (copyedit/layout/DOI minted)</strong></td> <td data-col-size="md" data-start="1236" data-end="1260">Full production steps</td> <td data-col-size="md" data-start="1260" data-end="1285">US$ 250</td> </tr> <tr data-start="1286" data-end="1420"> <td data-start="1286" data-end="1317" data-col-size="md"><strong data-start="1288" data-end="1316">Online-first / Published</strong></td> <td data-col-size="md" data-start="1317" data-end="1345">Published record creation</td> <td data-col-size="md" data-start="1345" data-end="1420"><strong data-start="1347" data-end="1384">Retraction processing fee </strong>US$300— see Retraction Policy</td> </tr> </tbody> </table> </div> </div> <p><strong>Effective immediately:</strong>Once an article is accepted for publication and the Article Processing Charge (APC) is paid, the APC is strictly non-refundable.<br data-start="321" data-end="324" />This applies regardless of subsequent author requests (e.g., withdrawal after acceptance, authorship changes, institutional funding issues) or post-acceptance outcomes (e.g., retraction, removal, or corrections).</p> <p><strong>Publication schedule. </strong>The journal publishes articles online under CC-BY licence 4.0 within six weeks after acceptance as continuous publication to avoid any delays. </p> <p><strong>Copyright. </strong>Individual articles are published Open Access under the <a href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Licence: CC-BY 4.0</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Authors retain copyright in their articles, but grant Journal the right of the first publication. </p> <p><strong>Long-term archiving policy</strong>. Journal deposits the articles that it publishes in digital archives <a href="http://www.portico.org/digital-preservation/about-us/our-organization">Portico</a>, <a href="https://www.clockss.org/clockss/Home">CLOCKSS</a>, <a href="https://www.lockss.org/about/what-is-lockss/">LOCKSS </a>to guarantee long-term digital preservation. <a href="http://www.portico.org/digital-preservation/about-us/our-organization">Portico</a> is among the largest community-supported digital archives in the world. <a href="https://www.clockss.org/clockss/Home">CLOCKSS </a>(<em>Controlled</em> LOCKSS) is a not-for-profit joint venture between the world’s leading academic publishers and research libraries whose mission is to build a sustainable, geographically distributed dark archive with which to ensure the long-term survival of Web-based scholarly publications for the benefit of the greater global research community. The <a href="https://www.lockss.org/about/what-is-lockss/">LOCKSS</a> Program is an open-source, library-led digital preservation system built on the principle that “lots of copies keep stuff safe.”</p> <p><strong>Disclaimers. Current Science</strong> make every effort to ensure the accuracy of all the information (the "Content") contained in our publications. However, Journal, our agents, and our licensors make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content. Any opinions and views expressed in this publication are the opinions and views of the authors, and are not the views of or endorsed by Journal. The accuracy of the Content should not be relied upon and should be independently verified with primary sources of information. Current Science shall not be liable for any losses, actions, claims, proceedings, demands, costs, expenses, damages, and other liabilities whatsoever or howsoever caused arising directly or indirectly in connection with, in relation to, or arising out of the use of the Content. </p> <p>The journal is published by Current Science comply with the <a href="https://publicationethics.org/files/Principles_of_Transparency_and_Best_Practice_in_Scholarly_Publishingv2_0.pdf">Principles of Transparency and Best Practice in Scholarly Publishing </a>at all stages of the publication process.</p> <p> </p>https://currentscience.info/index.php/cs/article/view/2114Utilization of Silkworm Pupae-Derived Biochar for Cr(VI) Removal2026-07-23T10:57:10+00:00Qin-wen Zhengjczzzq@163.comQin-jin Weimartina@mail.ustc.edu.cnZhi-peng Zhangzzpwss123@126.comShan-shan Guoshanshanguo9933@163.comJin-yan Yangyanyang@scu.edu.cnXiao-ke Guogxiaoke9999@163.comyuanyue liuliuyuanyue@scaes.cn<p>Silkworm pupae, a prevalent agricultural residue in China, are rich in proteins and polysaccharides, offering significant potential for resourceful utilization. This study investigates the application of silkworm pupa-derived biochar for the removal of hexavalent chromium [Cr(VI)] from water. Biochar was produced through pyrolysis at 300 °C, 400 °C, and 500 °C at varying retention times. The silkworm pupa biochar produced at 300 °C exhibited effective Cr(VI) removal under acidic conditions (pH < 3), at a relatively low temperature of 15 °C, and with an adsorbent dosage below 5 g/L, reaching a maximum adsorption capacity of 1.476 mg/g. The adsorption process was consistent with the pseudo-second-order kinetic equation and the Freundlich isotherm adsorption model, which indicate that the adsorption of Cr(VI) by the biochar proceeded simultaneously with membrane diffusion and intraparticle diffusion. Some oxygen-containing functional groups and C=C groups were involved in the adsorption process. The study highlights the feasibility of using silkworm pupa biochar as a sustainable and economically viable adsorbent for wastewater remediation. These findings provide a potential approach for utilizing agricultural waste in environmental management, contributing to both waste treatment and pollution control.</p>2026-09-03T00:00:00+00:00Copyright (c) 2026 Current Sciencehttps://currentscience.info/index.php/cs/article/view/2123An Integrated Drone-Borne Magnetics and Multi-Scale Satellite Remote Sensing to Delineate Structural Controls on Groundwater Accumulation in Hard-Rock Aquifers of Ghumnur Khurd surroundings, Komaram Bheem Asifabad Dist., Telangana, India2026-07-28T06:04:40+00:00Narasimha Bommuraobn@spectrageoservices.comNagarajan Praobn@spectrageoservices.comCyriac Josephraobn@spectrageoservices.com<p><em>A high-resolution drone-borne magnetic survey was integrated with multi-scale satellite remote sensing over approximately 10</em><em> Km<sup>2</sup> </em><em>of tribal agricultural land in Komaram Bheem Asifabad district, northern Telangana, India, to identify subsurface dolerite dykes and assess their potential as natural barriers for passive groundwater storage</em><em>. A total of 23,432 magnetic readings were acquired at 10Hz using a UAV- mounted proton precession magnetometer at a mean altitude of 581m amsl. Total Magnetic Intensity (TMI) data were processed to generate residual anomaly, Reduction to Pole (RTP), and Analytic Signal maps. Three distinct dolerite dykes were delineated: two NW–SE trending bodies (Dyke A: +949nT; Dyke 2: +160nT) and one NE–SW cross-cutting lateral barrier (Dyke 3: +198nT). Dip directions and geometries were determined using the North–South magnetic gradient asymmetry method and independently validated by satellite terrain slope, geomorphology, and lineament density maps. Both NW–SE dykes dip northward at 65<sup>0</sup>–80°, directly opposing the regional NNE → SSW groundwater flow, creating highly effective natural subsurface dams. Peters’ half-width depth estimates place the top of the dyke intrusions at 30–55m, with basement depths varying between 75m and 134m along three modelled depth profiles. Total passive groundwater storage potential is estimated at 8.3 million litres, which scales to 11.1 million litres with targeted surface check dam integration. Eight priority borewell locations and five surface check dam sites are proposed to enhance community water security. Published regional data indicate acceptable water quality for drinking and irrigation; however, mandatory fluoride testing is required at each borehole prior to commissioning due to localized geogenic risks. This study demonstrates that integrated drone magnetic workflows, cross-validated by multi-band satellite imagery and digital terrain layers; provide a rapid, non-invasive, and cost-effective paradigm for groundwater resource exploration in complex hard-rock aquifers. </em></p>2026-09-03T00:00:00+00:00Copyright (c) 2026 Current Sciencehttps://currentscience.info/index.php/cs/article/view/2125Evaluation for antidiabetic activities of flavonoids2026-07-28T15:49:30+00:00Yong Zhaozhaooy@126.comJunnan Lizhaooy@126.comFazhi Yuanzhaooy@126.comZhen Zangzhaooy@126.comQiuye Xuzhaooy@126.com<p>This study aims to evaluate the effects on antidiabetic activities of petroleum</p> <p>ether extract (SMPE), ethyl acetate extract (SMAE), and flavonoids isolated from</p> <p><em>Syzygium malaccense</em>. The results discovered compounds <strong>2</strong>, <strong>5</strong>, <strong>7</strong>, and <strong>9 </strong>exhibited</p> <p>weak inhibitory activity against <em>α</em>-glucosidase with percent inhibition rate of</p> <p>2.74±0.26 ~ 10.20±0.33 at 1.00×10 -6 mol/L and <strong>9 </strong>showed weak promotion on glucose</p> <p>consumption in HepG2 cells with consumption rate of 4.03±2.70 % at 1.00×10 -6</p> <p>mol/L. All compounds were firstly tested their HepG2 cells glucose consumption</p> <p>activities, and <strong>6 </strong>and <strong>8 </strong>~ <strong>10 </strong>were the first report on their <em>α</em>-glucosidase inhibitory</p> <p>effect. This research provided new evidences for antihyperglycemic activity of <em>S. </em></p> <p><em>malaccense.</em></p>2026-09-27T00:00:00+00:00Copyright (c) 2026 Current Sciencehttps://currentscience.info/index.php/cs/article/view/2127Chemical Constituents and Α-Glucosidase Inhibitory Activity of Syzygium Yunnanense2026-07-31T14:48:16+00:00Yong Zhaozhaooy@126.comJiayin Wangzhaooy@126.comMengjia Lizhaooy@126.comZhaojie Wangzhaooy@126.comMingxiang Lizhaooy@126.com<p>Type 2 diabetes represents a pervasive global public health challenge, necessitating the discovery of novel, safe, and efficacious antidiabetic agents. This study presents the first phytochemical investigation of <em>Syzygium yunnanense</em>, isolating 23 secondary metabolites. Compounds <strong>2</strong>, <strong>6</strong>, and <strong>8</strong>, whose <em>α</em>-glucosidase inhibitory activity is reported for the first time in this work, exhibited stronger in vitro inhibition than the positive control quercetin, with stable target binding validated via molecular docking. These results establish a scientific foundation for <em>S. yunnanense</em> as a promising antidiabetic medicinal resource. The antibacterial activity was also tested.</p>2026-09-27T00:00:00+00:00Copyright (c) 2026 Current Sciencehttps://currentscience.info/index.php/cs/article/view/2133Factors Associated with Conversion to General Anesthesia among Parturients Undergoing Cesarean Section with Neuraxial Anestheisa: A Case-Control Study2026-08-08T15:32:06+00:00Fei Jiajiafeijjfybjy@163.comXiaoqin Tangjiafeijjfybjy@163.comXiaoyan Chenjiafeijjfybjy@163.comChao Yangjiafeijjfybjy@163.comXiu Chenjiafeijjfybjy@163.comZhenji Wangjiafeijjfybjy@163.comXuanyue Liujiafeijjfybjy@163.com<p><strong>Objective</strong></p> <p>Pain during cesarean under neuraxial anesthesia is a concern for parturients. Some must convert to general anesthesia due to intense pain, increasing risks for the mother and neonate. The risk factors for this conversion are not well understood. We conducted a retrospective case-control study to identify potential independent factors.</p> <p><strong>Methods </strong></p> <p>We reviewed medical records to identify parturients who switched to general anesthesia during cesarean sections under initial neuraxial anesthesia and matched them 1:2 to the neuraxial anesthesia group. Univariate and multivariate binary logistic regression were used to analyze risk factors for conversion.</p> <p><strong>Result</strong></p> <p>Between 2016 and 2025, 30,692 parturients at our hospital had cesarean sections with initial neuraxial anesthesia. Of these, 3102 experienced intraoperative pain, and 56 (1.8%) required conversion to general anesthesia due to severe discomfort. Univariate binary logistic regression identified risk factors including advanced age, BMI <strong>< </strong>30, primigravidity, epidural anesthesia, repeat puncture, emergency surgery, and fatal weight. Multivariate regression showed advanced age, epidural anesthesia, repeat puncture, and emergency surgery as independent factors; fatal weight was marginally significant.</p> <p><strong>Conclusion</strong></p> <p>In conclusion, intraoperative pain is a common issue. The incidence of parturients converting from neuraxial to general anesthesia during cesarean delivery is low. Advanced age, multiple puncture attempts, initial epidural anesthesia, and emergency surgery are independent predictors of conversion to general anesthesia.</p> <p><strong>Keywords: </strong>Neuraxial anesthesia, General anesthesia, Cesarean section, Conversion</p>2026-09-16T00:00:00+00:00Copyright (c) 2026 Current Sciencehttps://currentscience.info/index.php/cs/article/view/2134A New Method Based on Feature Alignment for Multi-Center Machine Learning Survival Prediction in Nasopharyngeal Cancer Patients2026-08-08T00:56:54+00:00Daizheng Huanghuangdaizheng@gxmu.edu.cnSong Wuhuangdaizheng@gxmu.edu.cnJing Chenhuangdaizheng@gxmu.edu.cnWenhui Luhuangdaizheng@gxmu.edu.cnYuekun Weihuangdaizheng@gxmu.edu.cnQiong Songhuangdaizheng@gxmu.edu.cnChao Huanghuangdaizheng@gxmu.edu.cn<p><strong>Purpose</strong> In the survival prediction of multi-center nasopharyngeal carcinoma patients, the inconsistency of data characteristics across different centers significantly affects the predictive performance of data-driven machine learning methods. This study explores how to improve the effectiveness and consistency of multi-center data through feature alignment and fusion techniques, thereby optimizing the performance of survival prediction models.</p> <p><strong>Methods </strong>We collected two sets of nasopharyngeal cancer data sets.After feature alignment, LASSO regression was used to screen the features in the aligned latent space to select the most discriminative features. Subsequently, we introduced 15 mainstream machine learning algorithms for survival prediction model training, selecting multidimensional metrics such as AUC, F1-score, Accuracy, and Recall for evaluation.Additionally, to validate the superiority of the method, we applied Pearson correlation and the Boruta algorithm to train the aforementioned 15 machine learning models separately on both datasets and compared the performance results. Combining the encoder weights of an Autoencoder, the SHAP importance is back-projected from the latent space to the original feature variables to analyze the factors influencing the survival of NPC patients.</p> <p><strong>Results </strong>All evaluation metrics (AUC, F1 score, precision) exceeding 0.97.This approach successfully mitigated multi-centre data heterogeneity while validating the robust generalisation capability and stability of these models within multi-centre data environments.SHAP interpretability analysis revealed that the feature combinations of gender + time, age + time, and primary site + age exhibited the broadest SHAP value distributions, representing the most influential feature combinations affecting survival risk prediction.</p> <p><strong>Conclusion </strong>The data heterogeneity issue associated with multi-center NPC survival prediction was effectively resolved by combining autoencoder-based feature alignment with adversarial training.</p>2026-09-03T00:00:00+00:00Copyright (c) 2026 Current Sciencehttps://currentscience.info/index.php/cs/article/view/2137Circular RNA circASAP1 facilitates gastric cancer progression by sponging miR-874-3p and upregulating CPEB42026-08-09T08:44:20+00:00Han Zhang40815481@qq.comChuan Qin40815481@qq.comLei Liu40815481@qq.comJinkun Zhong40815481@qq.com<p>Gastric cancer (GC) ranks as the fifth most prevalent malignancy globally and the fifth leading cause of cancer-related mortality. Although age-standardized incidence rates have declined gradually over recent decades, the absolute case burden continues to rise, driven largely by population aging and demographic growth. The clinical outlook for advanced GC remains poor, creating an urgent need to dissect the underlying molecular mechanisms. Circular RNAs (circRNAs) are established post-transcriptional regulators across multiple cancer types; however, the functional roles of most circRNAs in GC pathogenesis remain poorly characterized. In this study, we identified a significantly upregulated circRNA, hsa_circ_0008934 (designated circASAP1), in GC tissues and cell lines through microarray profiling and qRT-PCR validation. Functional assays demonstrated that circASAP1 knockdown markedly suppressed, while its overexpression promoted, GC cell proliferation, colony formation, DNA synthesis, migration, and invasion in vitro. Mechanistically, circASAP1 acts as a competitive endogenous RNA (ceRNA) by directly sponging miR-874-3p, thereby derepressing the oncogenic target CPEB4. Luciferase reporter and RNA fluorescence in situ hybridization (FISH) assays confirmed the direct interactions among circASAP1, miR-874-3p, and the CPEB4 3′ untranslated region. Rescue experiments validated that the pro-tumorigenic effects of circASAP1 are mediated, at least in part, through the miR-874-3p/CPEB4 axis. These findings establish the circASAP1/miR-874-3p/CPEB4 regulatory cascade as a driver of GC progression and identify circASAP1 as a candidate prognostic biomarker and therapeutic target.</p>2026-09-03T00:00:00+00:00Copyright (c) 2026 Current Sciencehttps://currentscience.info/index.php/cs/article/view/2155One New Phloroglucinol Derivative with Α-Glucosidase Inhibitory Activity from Syzygium Austroyunnanense2026-08-24T13:27:46+00:00Yong Zhaozhaooy@126.comQiuye Xuzhaooy@126.comShaohua Xuzhaooy@126.comWen Xuzhaooy@126.comFazhi Yuanzhaooy@126.comMingxiang Lizhaooy@126.com<p>Type 2 diabetes mellitus (T2DM) represents a substantial global publichealth burden, highlighting an urgent demand to discover new, safe and effective antidiabetic therapeutic agents. This study reports the isolation of one new phloroglucinol derivative (<strong>1</strong>) isolated from <em>Syzygium </em><em>a</em><em>ustroyunnanense</em><em> </em>and its <em>α</em>-glucosidase inhibitory activity with quercetin as the positive control. It showed moderate <em>α</em>-glucosidase inhibitory activity with inhibition rate of 51.46±0.49 % at 50 <em>μ</em>M.</p>2026-09-29T00:00:00+00:00Copyright (c) 2026 Current Sciencehttps://currentscience.info/index.php/cs/article/view/2166Associations between Atrial Fibrillation and Bone Mineral Density at Different Sites: A Mendelian Randomization Study2026-09-02T06:44:24+00:00Xin Lvlvxin0326@163.comJing Chicc-16384@139.comXin Zhanglvxin0326@163.com<p>Background: Observational studies have suggested that anti-osteoporosis therapies may increase the risk of atrial fibrillation (AF); however, whether bone mineral density (BMD) itself exerts a causal effect on AF remains unclear. This study systematically investigated the univariable causal relationship between AF and BMD at different skeletal sites, including the femoral neck, lumbar spine, forearm, and total body, to clarify the relationship between bone status and AF risk.</p> <p>Methods: We conducted a two-sample univariable Mendelian randomization (MR) analysis to evaluate the causal associations between AF and BMD measured at the femoral neck (FN-BMD), lumbar spine (LS-BMD), forearm (FA-BMD), and total body (TB-BMD). Summary statistics were obtained from large-scale genome-wide association studies (GWASs). The inverse variance-weighted (IVW) method was used as the primary method, with sensitivity analyses including Cochran’s Q test, the MR-Egger intercept test, and leave-one-out analyses.</p> <p>Results: The IVW analysis indicated positive associations of FN-BMD (odds ratio [OR] = 1.17, 95% confidence interval [CI]: 1.05–1.29,<em> P</em> = 0.003) and FA-BMD (OR = 1.15, 95% CI: 1.03–1.29, P = 0.01) with an increased AF risk. In contrast, lumbar spine bone mineral density (LS‑BMD) had a suggestive causal association with AF(OR = 1.12, 95% CI: 1.02‑1.23, P = 0.014).In contrast, no significant associations were detected for TB-BMD (OR = 1.02, 95% CI: 0.95–1.09, <em>P</em> = 0.64). Sensitivity analyses supported the robustness of these findings.</p> <p>Conclusion: This MR study provides genetic evidence that increased FN-BMD and FA-BMD is causally associated with an increased risk of AF, whereas lumbar spine bone mineral density (LS‑BMD) exerted a suggestive causal effect, whereas total‑body bone mineral density (TB‑BMD) showed no significant causal effect.. These results highlight novel links between skeletal health and cardiovascular disease.</p>2026-09-29T00:00:00+00:00Copyright (c) 2026 Current Sciencehttps://currentscience.info/index.php/cs/article/view/2179Evaluation of Neolamarckia cadamba (Roxb.) Methanolic Extract Loaded Niosomal Gel for Anti- Inflammatory and Anti- Rheumatic Activity2026-09-14T15:54:14+00:00Richa Pandeyrichapandey83880@gmail.comSmita Jainrichapandey83880@gmail.comS Nayakrichapandey83880@gmail.com<p><em>Neolamarckia cadamba </em>is a medicinal plant known for its anti-inflammatory and therapeutic properties. The present study aimed to evaluate the anti-inflammatory and anti-rheumatic activities of <em>Neolamarckia cadamba </em>leaf extract and its niosomal formulation. The leaf extract was prepared by Soxhlet extraction and formulated into niosomes to enhance its therapeutic efficacy. Anti-inflammatory activity was assessed using protein denaturation inhibition and HRBC membrane stabilization assays, while anti-rheumatic activity was evaluated by protein denaturation and anti-collagenase inhibition methods. The results demonstrated concentration-dependent activity for both the extract and niosomal formulation. However, the niosomal formulation exhibited significantly higher inhibition and membrane stabilization compared to the crude extract in all assays. The enhanced activity may be attributed to improved stability, bioavailability, and sustained release of phytoconstituents. The findings support the traditional use of <em>Neolamarckia cadamba </em>and suggest that niosomal drug delivery systems can be a promising approach for the treatment of inflammatory and rheumatic disorders.</p>2026-09-16T00:00:00+00:00Copyright (c) 2026 Current Sciencehttps://currentscience.info/index.php/cs/article/view/2149Research Progress on Chinese Herbal Medicines for Gastrointestinal Diseases: A Review2026-08-16T16:24:19+00:00Hongmei Luoanszyylhm@163.comJi Mamatthewmj@yeah.net<p>Gastrointestinal diseases are prevalent clinical conditions that significantly impair patients’ quality of life, manifesting symptoms such as epigastric and abdominal distension and pain, food retention, and loss of appetite. Traditional Chinese herbal medicines have a long history and demonstrated efficacy in treating these disorders, characterized by their multi-target and multi-pathway therapeutic actions, which have garnered increasing attention from researchers worldwide. This review systematically summarizes the pharmacodynamic material basis, pharmacological mechanisms, and clinical research progress of several common Chinese herbs, including Yunmuxiang (Aucklandia lappa), Chenpi (Citrus reticulata peel), Shan Zha (Crataegus pinnatifida), Baizhu (Atractylodes macrocephala), and Houpu (Magnolia officinalis), in managing epigastric and abdominal distension and pain, food retention, and loss of appetite. Special emphasis is placed on the gastrointestinal motility regulation and anti-inflammatory activities of costunolide and dehydrocostus lactone, the main active sesquiterpene lactones in Yunmuxiang. Additionally, the review integrates the compatibility principles of related compound formulations with modern pharmacological evidence to provide a comprehensive understanding. The aim is to offer theoretical support and clinical references for the application of traditional Chinese medicine in the treatment of gastrointestinal diseases.</p>2026-09-26T00:00:00+00:00Copyright (c) 2026 Current Science